Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPPRADO-RIBEIRO, A. C.SANTOS-SILVA, A. R.FONSECA, F. P.SCARINI, J. F.INNOCENTINI, L. M. A. R.BRANDãO, T. B.2023-12-042023-12-042023Prado-Ribeiro, A. C.; Santos-Silva, A. R.; Fonseca, F. P.; Scarini, J. F.; Innocentini, L. M. A. R.; Brandão, T. B.. Oral Management of Cancer Patients After Multimodality Therapy. In: . Clinical Decision-Making in Oral Medicine: A Concise Guide to Diagnosis and Treatment: SPRINGER INTERNATIONAL PUBLISHING, 2023. p.155-166.978-303114945-0; 978-303114944-3https://observatorio.fm.usp.br/handle/OPI/57245No currently available anticancer treatment, whether radiotherapy or chemotherapy, can kill neoplastic cells without affecting normal cells. In this context, the oral mucosa epithelium is susceptible to acute and chronic toxicities of antineoplastic treatment. This chapter offers an update on the main oral toxic effects of radiotherapy and chemotherapy and how to adequate individualize treatment based on the recommendations of preventative and interventional treatments for these patients. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.engrestrictedAccessCariesChemotherapyDry mouthDysgeusiaHemorrhageHyposalivationMucositisOsteoradionecrosisPseudomembranous candidiasisRadiotherapyToxicities of antineoplastic treatmentTrismusXerostomiabookPartCopyright SPRINGER INTERNATIONAL PUBLISHING10.1007/978-3-031-14945-0_22